|
August 2026 No images? Click here
Hello and welcome to this month's Loop+ Loop PLUS builds on everything you love about Loop, offering added depth and insight into the work we do and updates from our team. Have your say Your voice matters: Help us improve the journey to diagnosis
If you have been diagnosed with neuroendocrine cancer Your experience could help improve neuroendocrine cancer diagnosis We have launched a new survey to better understand patients' experiences of the journey to diagnosis, from first symptoms through to receiving a neuroendocrine cancer diagnosis. Whether your diagnosis was reached quickly or followed months or years of uncertainty, your experiences can help identify barriers to earlier diagnosis and improve support, awareness, education and care for future patients. Every person's experience provides valuable insight into the realities of living with neuroendocrine cancer. By participating in this survey, you will help us better understand the challenges patients face today and identify areas where greater awareness, education and support are needed. The findings will be used to inform future advocacy work, support services, research initiatives, healthcare education and policy development. All responses will be anonymous, so you can share your experiences openly and honestly. CLICK HERE to take part in the patient survey If you are a family member or carer Your experience matters; improving support for families, friends and caregivers We have also launched a survey to better understand the experiences, challenges and support needs of those who have cared for or supported someone living with neuroendocrine cancer. Whether you provided emotional support, practical help, advocacy or personal care, your insights can help shape future services, education, research and policy. For more information on how to take part, please visit our website. National Cancer Strategy for Wales: Have your say The Welsh Government is developing a National Cancer Strategy for Wales to improve cancer outcomes, including increasing survival rates and reducing cancer-related deaths. An open call for evidence is now inviting views from individuals and organisations across Wales. Responses can be based on personal experience, professional expertise, research evidence, or organisational perspectives. Evidence, examples, and recommendations are welcomed, but all views will be considered. Find out more and access the consultation documents here Support & Wellbeing Try one of our popular Group Therapy Programmes
Living with neuroendocrine cancer can affect many areas of life, including physical health, emotional wellbeing, relationships, work, and confidence about the future. For many people, especially those living with a rare cancer, feelings of isolation and loneliness can be one of the greatest challenges. Research shows that professionally facilitated group support can help reduce feelings of isolation and anxiety, improve coping skills, strengthen resilience, and provide valuable emotional and practical support. Many people tell us that meeting others who understand their experience helps them feel reassured, supported, and more confident in managing life with cancer. At Neuroendocrine Cancer UK, our FREE online group therapy programmes, run by specialist mental health and wellbeing provider Rareminds, are designed to help people live well with neuroendocrine cancer, providing opportunities to connect, learn, and build long-term wellbeing. “I can recommend the family and carers one, I did it a couple of years ago and found it really good” “I did the mindfulness course. Definitely worthwhile.” It's easy to register:
So why not take a look and see if one of the programmes might be right for you. New pilot support programme: Solution-Focused Hypnotherapy
We're excited to launch a new 8-week online Solution-Focused Hypnotherapy pilot programme for people living with neuroendocrine cancer. Led by a hypnotherapist with nearly 20 years' experience in the neuroendocrine cancer community, weekly sessions combine supportive discussion, practical stress-management techniques and guided hypnosis to help participants manage anxiety, fatigue and the uncertainties that can come with living with neuroendocrine cancer. This pilot programme will help us explore whether Solution-Focused Hypnotherapy could become a permanent addition to our package of support services. Support Groups: more than just a meeting
Neuroendocrine cancer can sometimes feel like a lonely diagnosis, but nobody should have to navigate it alone. Through shared experiences, compassionate listening, practical knowledge and genuine understanding, peer support helps people find connection, confidence and hope. The message we hear time and again from those attending our groups is simple: meeting others who understand makes a difference: "I wish I had found the group sooner." We are delighted to see our community come together and our support groups grow, with 8 groups started, re-started or starting in 2026: Local in-person: Amersham, Birmingham, Coventry, Exeter, Hastings and North Wales Online: Aberdeen, Highlands & Islands, and Kent For NCUK, patient support groups are not simply meetings. They are communities built on understanding, compassion and shared experience. They help people navigate diagnosis, treatment, survivorship, loss and everything in between. That is why Neuroendocrine Cancer UK remains committed to supporting and coordinating patient support groups across the UK, ensuring that everyone affected by neuroendocrine cancer has the opportunity to connect with others, find support and know they belong. Find out more or contact the NCUK Support Team here. Register for our September and October webinars
September webinar: Every Moment Matters Join us for the second webinar in our Every Moment Matters series, exploring personalised end-of-life care and what matters most to people affected by neuroendocrine cancer. This supportive and compassionate session will provide an opportunity to discuss important questions, share experiences, and explore concerns around planning, preferences, and care. Date: 30 September 2026 October webinar: NETworking for Life Join our Patient Ambassadors for the fourth webinar in the NETworking for Life series, focusing on the realities of living and working with neuroendocrine cancer. Drawing on their own experiences, our Ambassadors will share insights into balancing treatment, work, family life, and wellbeing while navigating a long-term diagnosis. Date: 21 October 2026 We hope you can join us for these informative and supportive community events. Research & education Research study: Share your experience of nutrition and physical activity during cancer treatment We are delighted to support a new research study being led by the NIHR Cancer and Nutrition Collaboration and the University of Southampton, which aims to better understand patients' experiences of receiving information about nutrition and physical activity during cancer treatment. The research team is seeking feedback from adults who have received cancer treatment in the UK within the last five years. Through an anonymous online survey, participants will be asked about the information, advice and support they received regarding nutrition and physical activity, as well as what additional information may have been helpful during their treatment journey. The findings will help improve the quality of information and support provided to future cancer patients across the NHS and other healthcare settings. The survey takes approximately 15 to 20 minutes to complete, and all responses are anonymous. Participation is entirely voluntary. If you have received cancer treatment since January 2021, were treated within the NHS, are aged 18 or over, and can complete the survey in English, your experiences could make a valuable contribution to this important work. This study has been approved by the University of Southampton Research Ethics Committee (Reference: 110081). Good communication in cancer care Three patients who took part in the first Broncho-Pulmonary Education Event for HCPs in Manchester January this year have written an article for Thorax Journal entitled: What Makes Good Communication in Cancer Care: The Patient's Perspective. In the article, Kate Quirk, Lisa Webb and Melanie Lucas (pictured left to right below), share their experiences of cancer care to help educate healthcare professionals about the importance of good communication in a patient's journey. Read the full article on our website here.
Pictured: Professor Was Mansoor, Melanie, Lisa, Kate, and Professor Matt Evison at the Broncho-Pulmonary event in January
A Day in the Life of a Clinical Scientist
Clinical Scientist, Anne-Marie Stapleton, is based at the Royal Surrey County Hospital and has worked in Nuclear Medicine Physics since 2010. What does a typical day look like for you? "My role is varied and responsive to the needs of our service. I spend time directly supporting patients, carrying out radiation protection pre-assessments, and giving clear, practical advice before, during and after Molecular Radiotherapies such as Peptide Receptor Radionuclide Therapy (PRRT)..." NCUK news & updates Welcome to Mary, our new AmbassadorThis month, we welcome new Ambassador, Mary, to NCUK. "I'm Mary, 28, and my partner Tom was diagnosed with stage 4 neuroendocrine tumours last year, aged just 27. His cancer started in his pancreas and has spread to his liver."
Policies: the latest developments Here's a round up of all the latest policy developments that affect the neuroendocrine cancer community. You can read more by following the links to our website below. National Cancer Plan (England) Cancer52 Update: Six Months On The National Cancer Plan was launched to improve cancer prevention, diagnosis, treatment, research and support across England. Six months on, NHS England and the Department of Health and Social Care have provided an update on progress, highlighting areas of improvement while acknowledging that there is still much work to do. Read the update here. Cabozantinib approval in Scotland We warmly welcome the Scottish Medicines Consortium (SMC) decision to approve Cabozantinib for restricted use within NHS Scotland for some people living with advanced neuroendocrine tumours. Read the full story here. NICE cabozantinib appraisal appeal In an encouraging development for the neuroendocrine cancer community, an appeal relating to NICE's appraisal of Cabozantinib for advanced neuroendocrine tumours has upheld three key appeal points and the appraisal has been remitted back to the NICE appraisal committee for further consideration. Read the full story here. Timms Review update: help shape the future of PIP The co-chairs of the Timms Review of Personal Independence Payment (PIP) have published an update outlining the next stage of the Review and how disabled people, and those with long-term health conditions, can continue to influence its recommendations. Find out more here.
|